EcoDrugPlus

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSACLG00000002935
Gene Symbol: LOC113022596
3 Cross references
367 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSACLG00000021968
Gene Symbol: LOC113037171
3 Cross references
214 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSACLG00000002350
Gene Symbol: RPL10A
3 Cross references
380 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSACLG00000022487
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSACLG00000025763
Gene Symbol: RPL12
3 Cross references
489 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSACLG00000001642
Gene Symbol: RPL13
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSACLG00000016552
Gene Symbol: RPL13A
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSACLG00000005462
Gene Symbol: RPL14
3 Cross references
304 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSACLG00000017838
Gene Symbol: RPL15
3 Cross references
376 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSACLG00000009583
Gene Symbol: RPL17
1 Cross references
324 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSACLG00000020938
Gene Symbol: RPL18
1 Cross references
379 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSACLG00000008450
Gene Symbol: RPL18A
3 Cross references
369 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).